The role of embolic protection devices in renal angioplasty and stenting

Vascular Disease Management

Volumn 4, Issue 3, 2007, Pages 99-111

  Henry, Michel ^a,b,c   Henry, Isabelle ^a   Klonaris, Christos ^d   Polydorou, Antonio ^e   Polydorou, Amanda ^f   Hugel, Michele ^b,c  

^a Cabinet de Cardiologie ^*  (France)

^b Cabinet de Cardiologie   (France)

^c Global Research Institute   (India)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e IASO GENERAL HOSPITAL   (Greece)

^f Alexander S Onassis Public Benefit Foundation   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

ADULT; AGED; ANGIOPLASTY; ASPIRATION; ATHEROSCLEROSIS; BALLOON OCCLUSION; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EMBOLISM; FEMALE; FILTER; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; REVIEW; SOLITARY KIDNEY; STENT;

EID: 34249819068     PISSN: 15538036     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 2002;77:309-316.
2. Missouris CG, Buckenham T, Cappucio FP, et al. Renal artery stenosis: A common and important problem in patients with peripheral vascular disease. Am J Med 1994;96:10-14.
3. Gross CM, Krämer J, Waigland J, et al. Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cath Cardiovasc Diagn 1998;45:1-8.
4. Jean WJ, al-Bitar I, Zwicke DL, et al. High incidence of renal artery stenosis in patients with coronary artery disease. Cath Cardiovasc Diagn 1994;32:8-10.
5. O'Neil EA, Hansen KJ, Canzanello VJ, et al. Prevalence of ischemic nephropathy in patients with renal insufficiency. Am Surg 1992;58:485-490.
6. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: A population based study. J Vasc Surg 2002;36:443-451.
7. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Uro Clin North Am 1984;11:383-392.
8. Strandness DE Jr. Natural history of renal artery stenosis. Am J Kidney Dis 1994;24:630-635.
9. Zierler RE. Screening for renal artery stenosis: Is it justified? Mayo Clin Proc 2002;77:307-308.
10. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu's disease). Circulation 1989;80:429-437.
11. Sharma S, Jain AK. Natural history of non-specific aortoarteritis. In Panja M (ed). Non-specific Aorto Arteritis. Marksman Media Services Kolkata (India) 2001:p.165.
12. Goncharenko V, Gerlock AJ, Schaff MI, et al. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on Angiography. Radiology 1981;139:45-50.
13. Knutson DW, Abt AB. Pathophysiology, pathology and clinical features of renovascular hypertension. In D Eugene Strandness, JR Arena Van Breda (eds): Vascular Diseases. New York: Churchill Livingstone Inc., 1994:p.673.
14. Berglund G, Anderson O, Wilhelmsent. Prevalence of primary and secondary hypertension studies in a random population sample. BMJ 1976;2:pp.554-556.
15. Pickering TG. Renovascular hypertension: Medical evaluation and non surgical treatment. In Laragh JM, Brenner BM (eds): Hypertension: Physiopathology, Diagnosis and Management. New York: Raven Press, 1990:p1539.
16. Messena LM, Zelenock GB, Yaok A, et al. Renal vascularization for recurrent pulmonary oedema in patients with poorly controlled hypertension and renal insufficiency: A distinct subgroup of patients with atherosclerotic renal artery occlusive disease. J Vasc Surg 1994;20:76-87.
17. Stane Y, Gyepes MT, Olson DL, et al. Renovascular hypertension in children and adolescents. Radiology 1978;129:123-128.
18. Sos TA, Pickering TG, Sniderman K, et al. Percutaneous transluminal angioplasty in renovascular hypertension due to atheroma or fibromuscular hyperplasia. N Engl J Med 1983;309:274-278.
19. Edwards MS, Craven TE, Borke GL, et al. Renovascular disease and the risk of adverse coronary events in the elderly - A prospective, population based study. Arch Intern Med 2005;165:207-213.
20. Fried LF, Shlipak MG, Crump C, et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003;41:1364-1372.
21. Johansson M, Herlitz H, Jensen G, et al. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathic activation, renal function and treatment regimens. J Hypertens 1999;17:1743-1750.
22. Shlipak MG, Fried LF, Crump C, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 2002; 62:997-1004.
23. Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003;107:87-92.
24. Novick AC. Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease: Ten year's experience. JAMA 1987;257:498-501.
25. Weibull H, Bergqvist D, Bergentz SE, et al. P.T.R.A. versus surgical reconstruction of atherosclerotic renal stenosis: A prospective randomized study. J Vasc Surg 1993;18:841-852.
26. Cambria RP. Surgery: Indications and variables that affect procedural outcome, as well as morbidity and mortality. J Invasive Cardiol 1998;10:55-58.
27. Van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomized trial. Lancet 1999;353:282-286.
28. Henry M, Amor M, Henry I, et al. Stents in the treatment of renal artery stenosis: Long-term follow-up. J Endovasc Surg 1999;6:42-51.
29. Henry M, Amor M, Henry I, et al. Stent placement in the renal artery: Three-year experience with the Palmaz stent. J Vasc Interv Radiol 1996;7:343-350.
30. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal artery stenosis with vascular endoprotheses after unsuccessful balloon angioplasty. N Engl J Med 1997;336:459-465.
31. Van de Ven PJ, Beutler JJ, Kaatee R, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 1995;346:672-674.
32. Dorros G, Jaff M, Jain A, et al. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 1995;75:1051-1055.
33. Isles CG, Robertson S, Hill D. Management of renovascular disease: A review of renal artery stenting in ten studies. Q J Med 1999;92:159-167.
34. Boisclair C, Therasse E, Olivia VL, et al. Treatment of renal angioplasty failure by perculaneous renal artery stenting with Palmaz stents: Midterm technical and clinical results. AJR Am J Roentgenol 1997;168:245-251.
35. Hiramoto J, Hansen KJ, Pan WM et al. Atheroemboli during renal artery angioplasty: An ex vivo study. J Vasc Surg 2005;41:1026-1030.
36. Henry M, Klonaris C, Henry I. Renal stenting with the Percusurge Guardwire device: A pilot study. J Endovasc Ther 2001;8:227-237.
37. Henry M, Henry I, Klonaris C, et al. Renal angioplasty and stenting under protection. The way for the future? Catheter Cardiovasc Interv 2003;60:299-312.
38. Henry M, Henry I, Polydorou A, et al. Renal angioplasty and stenting: Long-term results and the potential role of protection devices. Expert Review Cardiovasc Ther 2005;3:321-334.
39. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003;114:44-50.
40. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularisation in clinical trials. American Heart Association. Circulation 2002;106:1572-1585.
41. Iannone LA, Underwood P, Nath A, et al. Effect of primary balloon expandable renal artery stents on long-term patency, renal function and balloon pressure in hypertension and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn 1996;37:243-250.
42. Taylor A, Sheppard D, MacLeod MJ, et al. Renal artery stent placement in renal artery stenosis: Technical and early clinical results. Clin Radiol 1997;52:451-457.
43. Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal artery stenting on progression of renovascular renal failure. Lancet 1997;349:1133-1136.
44. Paulsen D, Klow NE, Rogstad B, et al. Preservation of renal function by percutaneous transluminal angioplasty in ischemic renal disease. Nephrol Dial Transplant 1999;4:1454-1461.
45. Rodriguez-Lopez JA, Werber A, Ray L, et al. Renal artery stenosis treated with stent deployment: Indications, technique and outcome in 108 patients. J Vasc Surg 1999;29:617-624.
46. Rundback JH, Manoni T, Rozenblit GN, et al. Balloon angioplasty or stent placement in patients with azotemic renovascular disease: A retrospective comparison of clinical outcomes. Heart Dis 1999;1:121-125.
47. Guerrero M, Kunjummen B, Khaleel R, et al. Stabilization of renal function after renal artery stenting. Am J Cardiol 2002;90:63H.
48. Allaqaband S, Shaikh F, Zaidi S, et al. Long term effects of renal artery stenting or renal function in patients with atherosclerotic renal artery stenosis and baseline creatinine of > 2.0 mg/dl (abstract). Am J Cardiol 2003;92(suppl):54 L.
49. Haller ST, Kennedy D, Khuder S et al. Acute renal injury with renal artery stenting (abstract). Circulation 2004;110(suppl):III-614.
50. Zeller T, Frank U, Muller C, et al. Stent supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control. J Endovasc Ther 2004;11:95-106.
51. Dorros G, Jaff M, Mathias L, et al. Multicenter Palmaz Stent renal artery stenosis revascularization registry report: Four-year follow-up of 1058 successful patients. Catheter Cardiovasc Interv 2002;55:182-188.
52. Fiala LA, Jackson MR, Gillespie DL, et al. Primary stenting of atherosclerotic renal artery ostial stenosis. Ann Vasc Surg 1998;12:128-133.
53. Plouin PF, Chatellier G, Darne B, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study group. Hypertension 1998;31:823-829.
54. White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: Utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 1997;30:1445-1450.
55. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-647.
56. Rocha Singh KJ, Miskkel GJ, Kathodi RE, et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Cathet Cardiovasc Intervent 1999;47:167-172.
57. Von Knorring J, Edgren J, Lepantalo M. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. Acta Radiol 1996;37:36-40.
58. Watson P, Madjipetrou P, Cow S, et al. Effects of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000;102:1671-1677.
59. Rocha Singh K. Renaissance trial: A prospective multicenter trial to confirm the safety and efficacy of the express SD stent. Presented at the ISET Meeting in Miami Beach, Florida, January 22-26, 2006.
60. La Batide-Alanore A, Azizi M, Froissart M, et al. Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol 2001;12:1235-1241.
61. Pattynama P, Becker GJ, Brown J, et al. Percutaneous angioplasty for atherosclerotic renal artery disease: Effect on renal function in azotemic patients. Cardiovasc Intervent Radio 1994;17:143-146.
62. Subramanian R, Silva JA, Ramee SR, et al. Beneficial effects of chronic renal insufficiency. Euro Heart J 2002;P577:97.
63. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular diseases. Circulation 2000;101:570-580.
64. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 2002;105:1285-1290.
65. Limbruno U, Micheli A, De Carlo M, et al. Mechanical protection of distal embolization during primary angioplasty: Safety, feasibility, and impact on myocardial reperfusion. Circulation 2003;108:171-176.
66. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: Early experience. J Vasc Surg 2003;38:962-968.
67. Walker C, Kowalski J, Knan M, et al. Proximal protection before distal protection: Preventing large atheroemboly during renal intervention. Am J Cardiol 2002;90:28H.
68. Nolan BW, Schermerhom ML, Rowell E, et al. Outcomes of renal artery angioplasty and stenting using low-profile systems. J Vasc Surg 2005;41:46-52.
69. Commeau P, Barragan P, Huret B, et al. Direct stenting in the treatment of renal artery stenosis: Immediate and in-hospital results. Am J Cardiol 2001;TCT 74.
70. Morice MC, Marco J, Laborde JC, et al. The French registry on renal stenting. Am J Cardiol 2002;90:67H.
71. Rocha Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: The Aspire 2 study. J Am Coll Cardiol 2005;46:776-783.
72. Thadani RI, Camargo CA Jr, Xavier RJ, et al. Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine (Baltimore). 1995;74:350-358.
73. Haqqie SS, Urizar RE, Singh J. Nephrotic-range proteinuria in renal atheroembolic disease: Report of four cases. Am J Kidney Dis 1996;28:493-501.
74. Krishnamurthi V, Novick AC, Myles JL. Atheroembolic renal disease: Effect on morbidity and survival after renovascularization for atherosclerotic renal artery stenting. Catheter Cardiovasc Interv 1999; 46:245-248.
75. Boero R, Borcam M, Ladarola GM, et al. Acute kidney failure caused by cholesterol embolism. Minerva Urol Nephrol 2000;52:119-122.
76. Goldstein JA, Kolluri R, Rocha Singh K. Technical considerations for renal artery stenting. Vascular Disease Management 2006;3:260-265.
77. Henry M, Henry I, Klonaris C, et al. Benefits of cerebral protection during carotid stenting with the percursurge guardwire system: Midterm results. J Endovasc Ther 2002;9:1-13.
78. Reimers B, Corvaja N, Moshiris A, et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 2001;104:12-15.
79. Roubin GS. Carotid angioplasty and stenting under cerebral protection: The standard of care. Presented at the International Congress XV in Scottsdale, Arizona, February 11-14, 2002.
80. Holden A. Renal angioplasty and stenting with distal protection. Presented at the All That Jazz Meeting in New Orleans, Louisiana, April 26-29, 2005.
81. Eggebrecht H, Haude M, Baumgart D, et al. A new temporary occlusion and aspiration system prevention of distal embolization during percutaneous transluminal renal angioplasty. J Intervent Cardiol 2000;13:339-342.
82. Li SS, Wang CH, Lam CW. Renal angioplasty under protection of the percusurge Guardwire Plus System. J Invasive Cardiol 2003;15:148-150.
83. Guerkens U, Mueller R, Soblik S, et al. A new protection device to prevent distal embolization in peripheral interventions: First results in renal and carotid arteries. Presented at the ACC Meeting in Anaheim, CA, March 12-15, 2000.
84. Edwards MS, Craven BL, Stafford J, et al. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg 2006;44:128-135.
85. Sos T, Trost D. The importance of renal stenting in ischemic nephropathy. Endovascular Today 2003;2:44-46.
86. Kulwant SH, Venkateswara KR. Atheroemboli Renal Disease. J Am Soc Nephrol 2001;12:1781-1787.